| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| The Ramaraju Surgical Cotton Mills Limited |
|
Particulars |
As at 31 March 2023 |
As at 31 March 2022 |
|
ASSETS |
|
|
|
Non-Current Assets |
|
|
|
Property, Plant & Equipments |
297.27 |
241.06 |
|
Capital Work-in-progress |
9.17 |
24.98 |
|
Investment Property |
0.05 |
0.06 |
|
Goodwill |
19.52 |
19.52 |
|
Intangible Assets Financial Assets |
0.61 |
0.02 |
|
Investments in Associates |
187.56 |
182.46 |
|
Other Investments |
0.08 |
0.12 |
|
Other Financial Assets |
7.62 |
4.11 |
|
Deferred Tax Assets (Net) |
4.87 |
0.79 |
|
Other Non-Current Assets |
1.22 |
17.42 |
|
Sub Total (A) |
527.98 |
490.52 |
|
Current Assets |
129.73 |
103.34 |
|
Inventories |
38.11 |
36.12 |
|
Financial Assets Trade Receivables |
3.03 |
8.48 |
|
Cash and Cash Equivalents |
0.07 |
0.93 |
|
Other Financial Assets |
2.00 |
1.88 |
|
Current Tax Assets |
0.67 |
2.40 |
|
Other Current Assets |
25.90 |
29.29 |
|
Sub Total (B) |
199.52 |
182.44 |
|
TOTAL ASSETS (A+B) |
727.50 |
672.97 |
|
EQUITY AND LIABILITIES |
|
|
|
Equity |
|
|
|
Equity Share Capital |
4.00 |
4.00 |
|
Other Equity |
258.55 |
288.66 |
|
Non-Controlling Interest |
5.36 |
5.21 |
|
Total Equity (A) |
267.91 |
297.87 |
|
Liabilities |
|
|
|
Non-Current Liabilities |
|
|
|
Financial Liabilities |
222.37 |
141.40 |
|
Borrowings |
|
|
|
Provisions |
0.89 |
0.80 |
|
Deferred Government Grants |
0.16 |
0.17 |
|
Sub Total (B) |
223.41 |
142.38 |
|
Current Liabilities |
|
|
|
Financial Liabilities |
|
|
|
Borrowings |
200.37 |
184.32 |
|
Trade Payables |
- |
- |
|
(i) Total Outstanding dues of micro enterprise and small enterprises |
3.16 |
0.92 |
|
(ii) Total Outstanding dues of creditors other than micro enterprise and small enterprises |
11.38 |
16.67 |
|
Other Financial Liabilities |
9.63 |
8.63 |
|
Other Current Liabilities |
7.72 |
16.78 |
|
Provisions |
3.91 |
5.39 |
|
Sub Total (C) |
236.18 |
232.72 |
|
TOTAL EQUITY AND LIABILITIES (A+B+C) |
727.50 |
672.97 |
|
PARTICULARS |
2023 |
2022 |
|
INCOME |
|
|
|
Revenue from operations |
407.11 |
432.14 |
|
Other Income |
2.68 |
1.87 |
|
Total Income |
409.79 |
434.01 |
|
EXPENSES |
|
|
|
Cost of Materials Consumed |
245.03 |
255.16 |
|
Purchases of Stock- in- Trade |
11.12 |
5.05 |
|
Changes in Inventories of Finished Goods and Work-in-Progress |
-3.49 |
-9.71 |
|
Employee Benefit Expenses |
49.25 |
40.43 |
|
Finance Cost |
31.59 |
20.77 |
|
Depreciation and Amortisation Expenses |
42.06 |
45.98 |
|
Other Expenses |
73.11 |
68.64 |
|
Total Expenses |
448.66 |
426.33 |
|
Profit / (Loss) before tax |
-38.87 |
7.69 |
|
Tax Expenses / (Savings) |
|
|
|
Current Tax |
- |
1.35 |
|
Current Tax relating to earlier years |
-0.06 |
- |
|
Deferred Tax |
-4.08 |
-2.08 |
|
Total Tax Expenses / (Savings) |
-4.14 |
-0.73 |
|
Profit / (Loss) for the year before share of Profit of Associates |
-34.73 |
8.42 |
|
Share of Net profit after tax of Associates accounted using equity method |
5.48 |
12.73 |
|
Profit for the Year |
-29.25 |
21.15 |
|
Other Comprehensive Income |
|
|
|
Item that will not be reclassified subsequently to Profit and Loss: |
|
|
|
Remeasurement (Losses) on defined benefit obligation (net) |
-0.35 |
-0.82 |
|
Less: Income tax Savings |
-0.10 |
-0.14 |
|
Add: Deferred Tax (including MAT Credit) |
0.10 |
0.14 |
|
Total |
-0.35 |
-0.82 |
|
Fair value Gain on Equity Instruments through OCI (Net) |
-0.04 |
-0.02 |
|
Share of OCI of Associates accounted for using the equity method |
0.00 |
-0.03 |
|
OCI - Foreign Currency Translation |
0.04 |
- |
|
Other Comprehensive Income / (Loss) for the year, net of tax |
-0.35 |
-0.87 |
|
Total Comprehensive Income / (Loss) for the year, net of tax |
-29.60 |
20.29 |
|
Profit / (Loss) for the attributable to : Shareholders of the company |
-29.37 |
21.44 |
|
Non controlling Interest |
0.11 |
-0.29 |
|
Total Comprehensive Income for the year attributable to : |
|
|
|
Shareholders of the company |
-29.71 |
20.57 |
|
Non controlling Interest |
0.11 |
-0.29 |
|
Earnings per Equity Share of 10/- each |
|
|
|
Basic |
-73.46 |
53.63 |
|
Diluted |
-73.46 |
53.63 |
|
Particulars |
31st March 2023 |
31 March 2022 |
|
A. Cash Flow from Operating Activities |
|
|
|
Net Profit after Tax as per Statement of Profit and Loss |
-38.87 |
7.69 |
|
Adjustments to reconcile profit before tax to cash generated by operating activities |
|
|
|
Depreciation and Amortization expenses |
42.06 |
45.98 |
|
Loss on Sale of Assets |
31.59 |
20.77 |
|
Finance Costs |
-2.23 |
-1.72 |
|
Government Grants |
-0.37 |
2.53 |
|
Interest Income |
-0.01 |
-0.01 |
|
Bad debts |
- |
0.11 |
|
Impairment Allowance for Trade Receivables |
0.54 |
0.11 |
|
Operating Profit before Working Capital Changes |
32.70 |
75.45 |
|
Net Change in: |
|
|
|
Inventories |
-0.89 |
16.08 |
|
Trade Receivables |
2.26 |
-1.79 |
|
Loans and Advances |
-26.39 |
-39.44 |
|
Trade Payables & Current liabilities |
-12.52 |
-0.88 |
|
Cash Generated from Operations |
-4.84 |
49.42 |
|
Income Tax |
-0.67 |
-2.35 |
|
Net cash generated from operating activities |
-5.51 |
47.07 |
|
B. Cash flows from investing activities |
|
|
|
Purchase of purchase of property, plant and equipment |
-68.45 |
-50.58 |
|
Investment in shares |
-2.12 |
-3.70 |
|
Declassification of Investment Pursuant to the scheme of Amalgamation |
- |
1.49 |
|
Proceeds From sale of property , Plant & Equipments |
1.96 |
1.90 |
|
Interest Received |
0.23 |
0.05 |
|
Dividend Received |
1.02 |
0.01 |
|
Net cash used in investing activities |
-67.37 |
-50.83 |
|
C. Cash flows from financing activities |
|
|
|
Long Term Borrowings |
|
|
|
Proceeds from Long Term Borrowings |
143.15 |
63.43 |
|
Repayment of Long Term Loan |
-61.22 |
-40.44 |
|
Short Term Borrowings |
|
|
|
Proceeds / (Repayment) of Deposits - Related Parties |
-8.78 |
2.42 |
|
Proceeds / (Repayment) of Short Term Borrowings (Net) |
23.86 |
7.20 |
|
Non-controlling Interest |
0.04 |
-2.41 |
|
Payment of Dividend |
-0.39 |
-0.20 |
|
Finance Cost |
-30.09 |
-20.77 |
|
Net Cash Flows from / (used in) Financing Activities |
66.56 |
9.24 |
|
Net Increase in Cash and Cash Equivalent (A+B+C) |
-6.31 |
5.47 |
|
Opening balance of Cash and Cash Equivalents |
9.42 |
3.91 |
|
Cash and Cash Equivalents acquired pursuant to Business Combination |
- |
0.03 |
|
Closing balance of Cash and Cash Equivalents |
3.11 |
9.42 |
|
Particulars |
31-Mar-23 |
31-Mar-22 |
|
Current Ratio (in times) |
1.02 |
0.93 |
|
Debt-Equity Ratio (in times) |
4.38 |
2.53 |
|
Return on Equity Ratio (in %) |
-29 |
8 |
|
Inventory Turnover Ratio (in times) |
101 |
67 |
|
Trade Receivables Turnover Ratio (in times) |
36 |
47 |
|
Trade Payable Turnover Ratio (in times) |
14 |
13 |
|
Net Capital Turnover Ratio (in times) |
123 |
101 |
|
Net Profit Ratio (in %) |
-7 |
2 |
|
Return on Capital Employed Ratio (in %) |
0 |
7 |
|
Particulars |
2023 |
2022 |
|
Dividend per Share |
0.50 |
1.00 |
|
Retained Earnings (In Rs. Crores) |
-5.73 |
24.42 |
Revenue from Operations:
In 2023, RSCML reported a revenue of ₹407.11 Crores, representing a 5.8% decrease compared to 2022. This decline may be attributed to factors such as decreased sales volume or lower selling prices, potentially impacting the company 's top-line performance.
Earnings per Equity Share (EPS):
In 2023, the EPS turned sharply negative at -₹73.46, whereas it stood at ₹53.63 in 2022. The negative EPS indicates that the company 's earnings were insufficient to cover the dividend commitments to its shareholders, potentially impacting investor confidence.
RSCML 's net profit ratio turned negative at -7% in 2023, down from 2% in 2022, indicating that the company 's profit margin eroded, possibly due to increased costs or pricing pressures.
ROCE significantly dropped to 0% in 2023 from 7% in 2022, highlighting a minimal return on the capital invested in the business. This suggests that the company may not have efficiently utilized its capital resources to generate profits.
ROE turned negative at -29% in 2023, compared to a positive 8% in 2022. The negative ROE indicates that the company 's equity base was eroded, and it failed to generate a return on shareholders ' investments, which is a critical concern for investors and stakeholders.
